Bonney's blue paint BP 1980
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
2 branded products available
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 3 · 1918–2026
Showing the 50 most relevant studies, sorted by most relevant.
S. Mennel, C. Meyer, J. Schmidt, et al.
Developments in ophthalmology, 2008
J. Bumpus, B. J. Brock
Applied and Environmental Microbiology, 1988
Matinise N
2025
Kaczorowska MA
2025
Pollution of water resources with hazardous substances of anthropogenic origin (e.g., synthetic dyes, heavy metal ions) is currently one of the most important environmental issues, and the development of not only effective and economical but also eco-friendly methods of removing these substances from aqueous solutions is one of the greatest challenges. Among the various separation methods, techniques based on the utilization of different types of polymer membranes have gained increasing interest due to their usually high efficiency, the materials' stability and reusability, and the possibility of using "green" components for their formation. Recent research efforts have been concentrated, inter alia, on the application of natural polysaccharide polymers (e.g., cellulose, alginates, starch, cyclodextrins) and their derivatives to produce well-performing membranes. Appropriately composed polysaccharide-based membranes under optimal process conditions enable effective separation of dyes, salts, and metal ions (e.g., often with a rejection rates of >95% for dyes and metal ions and <7% for salts). This review concerns the latest developments in the formation and utilization of novel polysaccharide-based membranes for the separation of synthetic dyes and metal ions from aqueous solutions and suspensions, with emphasis on their most important advantages, limitations, and potential impact on the environment and sustainability.
Abstract licence: CC BY
Wendy C. Andersen, S. Turnipseed, Christine M. Karbiwnyk, et al.
Analytica chimica acta, 2009
M. M. Martínez Bueno, Sonia Herrera, Ana Uclés, et al.
Analytica chimica acta, 2010
M. Oplatowska, R. Donnelly, R. Majithiya, et al.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2011
T. S. Algarni, A. M. Al-Mohaimeed, Naaser A. Y. Abduh, et al.
Catalysts, 2023
Ghanaim AM, Mahdy OME, Mohamed HI
2025
- Aspergillus flavus
- Seeds
- Azo Compounds
The worldwide textile industry extensively uses azo dyes, which pose serious health and environmental risks. Effective cleanup is necessary but challenging. Developing bioremediation methods for textile effluents will improve color removal efficiency. The recent attention to effectively utilizing microbes to convert toxic industrial azo dyes into non-hazardous compounds has garnered significant attention. In the present study, four fungal strains-Aspergillus flavus, Aspergillus terreus, Aspergillus niger, and Fusarium oxysporium-were employed to screen for the degradation and detoxification of azo dyes including congo red, crystal violet, bromophenol blue, and malachite green. After eight days, A. flavus had degraded azo dyes at the maximum proportion. The maximum decolorization (%) was achieved at 50 mg/L of dye concentration, 8 days of incubation, pH 6, 30 °C temperature, sucrose as a carbon source, NaNO3 as a nitrogen source, Ca+2 as minerals, and using static culture. The efficient production of laccases, lignin peroxidase, and manganese peroxidase enzymes by A. flavus proved that the enzyme played a crucial role in decolorizing the harmful azo dyes. The Fourier Transform Infrared spectrometer (FT-IR) data validated the decolorization and degradation process brought on by absorption and biodegradation. Compared to control plants, the results of the phytotoxicity assay showed that the degraded product was less harmful to maize and common bean plant's growth and germination rates. As a result, the findings indicate that A. flavus is a viable option for remediating azo dyes. This aids in the biodegradation of azo dyes found in wastewater.
Abstract licence: CC BY
Vitipon M, Akingbagbohun E, Rabilloud T
2025
A viability test for in vitro cultures, based on the intake of the textile dye alphazurine A by dead cells and its exclusion by viable cells, is described. This test uses the affinity of alphazurine A for proteins, so that the dye is retained in dead cells even after rinsing, while its anionic character prevents it from entering live cells. This feature makes this dye exclusion test amenable to a reading in a plate format. The alphazurine viability test provides an indicator of the absolute number of dead cells present in the culture well. To reach a cell viability index, a "dead cells" control (e.g. cells killed with ethanol) must be added. We also describe a double viability test, which first uses the alphazurine assay to provide the number of dead cells then a crystal violet assay to provide an index of the number of cells present in the plate. This double test provides a complete appraisal of the situation in the cell culture wells, and has been compared to other viability tests such as propidium iodide exclusion or tetrazolium reduction. Its performances to study the toxicity of substances such as pigments are also established, and allowed us to publish the first public toxicological data on the recently described Pigment Blue 86.
Abstract licence: CC BY-NC
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.